Connect with us

Hi, what are you looking for?

Investing

PolyPid Completes Manufacturing-Process Validation for D-PLEX

By Mary de Wet

PolyPid said Tuesday that it has produced three process-validation batches of D-PLEX, its lead drug candidate to prevent surgical-site infections, putting the company on track to seek regulatory approval.

The Israel-based biopharma company didn’t give a timeline for when it would submit new drug and marketing authorization applications…

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube